Pyxis Oncology, Inc. (PYXS)
NASDAQ: PYXS · Real-Time Price · USD
1.190
+0.040 (3.48%)
May 13, 2025, 4:00 PM - Market closed
Pyxis Oncology Market Cap
Pyxis Oncology has a market cap or net worth of $73.72 million as of May 14, 2025. Its market cap has decreased by -70.51% in one year.
Market Cap
73.72M
Enterprise Value
-33.01M
1-Year Change
-70.51%
Ranking
Category
Stock Price
$1.19
Market Cap Chart
Since the IPO on October 1, 2021, Pyxis Oncology's market cap has decreased from $523.75M to $73.72M, a decrease of -85.92%. That is a compound annual growth rate of -41.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2025 | 71.24M | -23.21% |
| Dec 31, 2024 | 92.77M | 16.32% |
| Dec 29, 2023 | 79.75M | 70.77% |
| Dec 30, 2022 | 46.70M | -86.78% |
| Dec 31, 2021 | 353.33M | -32.54% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.30B |
| Johnson & Johnson | 370.87B |
| UnitedHealth Group | 343.58B |
| AbbVie | 335.74B |
| Novo Nordisk | 292.03B |
| Abbott Laboratories | 229.64B |
| Novartis AG | 213.30B |
| AstraZeneca | 210.42B |